Generics
AB Science secures Canadian patent for AB8939, completing global IP coverage for AML treatment
12 June 2025 - French pharmaceutical company AB Science (Euronext Paris:AB) announced on Thursday that it has been granted a Canadian patent (CA 2975644) covering the composition of matter of AB8939 a...
Avera joins Civica to help maintain drug supplies
29 May 2025 - Non-profit generic pharmaceutical company Civica announced on Wednesday that Avera, a nonprofit healthcare provider in the Upper Midwest United States, has joined the company in helping ...
Apotex launches generic version of Tasigna in US market
28 May 2025 - US pharmaceutical company Apotex Corp announced on Tuesday the launch of nilotinib capsules, a generic version of Tasigna, in the United States, with 180 days of exclusivity.Nilotinib is...
CivicaScript launches droxidopa for symptomatic neurogenic orthostatic hypotension
11 April 2025 - CivicaScript LLC, a nonprofit focused on bringing low-cost generic medicines to US patients, announced on Thursday that it has launched its droxidopa in the United States.Droxidopa is ...
Padagis' Naloxone HCl Nasal Spray 4 mg obtains extended shelf-life of 36 months
3 April 2025 - US-based generic pharmaceutical manufacturer and supplier Padagis announced on Wednesday that the company's over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg has obtained an ext...
ANI Pharmaceuticals announces US launch of Nitazoxanide Tablets
19 March 2025 - Biopharmaceutical company ANI Pharmaceuticals Inc (Nasdaq:ANIP) announced on Wednesday the launch of its Nitazoxanide Tablets, 500 mg, the generic version of the reference listed drug ...